Nine year trends of dengue virus infection in Mumbai, Western India

Abstract

INTRODUCTION: Dengue virus (DENV) causes a wide range of diseases in humans, from acute febrile illness Dengue fever (DF) to life-threatening Dengue hemorrhagic fever (DHF) or Dengue shock syndrome (DSS). Factors believed to be responsible for spread of Dengue virus infection include explosive population growth, unplanned urban overpopulation with inadequate public health systems, poor standing water and vector control, climate changes and increased international recreational, business, military travel to endemic areas. All of these factors must be addressed to control the spread of Dengue and other mosquito-borne infections. The detection of Dengue virus RNA by reverse transcriptase PCR (RT-PCR) in human serum or plasma samples is highly indicative of acute Dengue fever. Moreover, the method is able to identify the Dengue virus serotype by demonstrating defined sequence homologies in the viral genomic RNA.

METHODS AND RESULTS: During the nine year period of this study analysis, 6767 strongly suspected cases were tested by RT-PCR. 1685 (24.9%) were Dengue PCR positive and confirmed as Dengue cases. Observations on the seasonality were based on the nine year's data as the intensity of sampling was at its maximum during monsoon season. Dengue typing was done on 100 positive samples after storage of Dengue RNA at – 80°C. Dengue serotypes were detected in 69 samples of which Dengue 2 was most predominant. 576 samples were processed for NS1 antigen and PCR simultaneously. 19/576 were positive (3.3 %) for NS1 as well as by PCR. 23/576 samples were negative for NS1 antigen, but were positive by RT-PCR. The remaining 534 samples which were negative for NS1 antigen were also negative by Dengue RT-PCR.

CONCLUSION: In this study we sought to standardize rapid, sensitive, and specific fluorogenic probe-based RT-PCR assay to screen and serotype a representative range of Dengue viruses that are found in and around Mumbai. Qualitative Dengue virus TaqMan assays could have tremendous utility for the epidemiological investigation of Dengue illness and especially for the study of the viremic response with candidate live-attenuated dengue virus vaccines.

Key words

Dengue - Mumbai - polymerase chain reaction

Publication History

Received: 22 December 2016

Accepted: 27 June 2017

Article published online:
19 February 2020

• References

• 1 World Health Organization. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. 2^nd ed. Geneva, Switzerland: World Health Organization; 1997. p. 12-47.
• 2 Gubler DJ, Kuno G, Sather GE, Velez M, Oliver A. Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. Am J Trop Med Hyg 1984;33:158-65.
• 3 Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992;30:545-51.
• 4 Laue T, Emmerich P, Schmitz H. Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system. J Clin Microbiol 1999;37:2543-7.
• 5 Drosten C, Göttig S, Schilling S, Asper M, Panning M, Schmitz H, et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol 2002;40:2323-30.
• 6 Morita K, Tanaka M, Igarashi A. Rapid identification of dengue virus serotypes by using polymerase chain reaction. J Clin Microbiol 1991;29:2107-10.
• 7 Callahan JD, Wu SJ, Dion-Schultz A, Mangold BE, Peruski LF, Watts DM, et al. Development and evaluation of serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for dengue virus. J Clin Microbiol 2001;39:4119-24.
• 8 Vijayakumar TS, Chandy S, Sathish N, Abraham M, Abraham P, Sridharan G. Is dengue emerging as a major public health problem? Indian J Med Res 2005;121:100-7.
• 9 Goh KT. Changing epidemiology of dengue in Singapore. Lancet 1995;346:1098.
• 10 Chan KL, Ng SK, Chew LM. The 1973 dengue haemorrhagic fever outbreak in Singapore and its control. Singapore Med J 1977;18:81-93.
• 11 Sharma S, Sharma SK, Mohan A, Wadhwa J, Dar L, Thulkar S, et al. Clinical Profile of Dengue Haemorrhagic Fever in Adults during 1996 – Outbreak in Delhi, India. Dengue Bulletin 1998;22:20-30.
• 12 Young PR, Hilditch PA, Bletchly C, Halloran W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol 2000;38:1053-7.
• 13 Vajpayee M, Mohankumar K, Wali JP, Dar L, Seth P, Broor S. Dengue virus infection during post-epidemic period in Delhi, India. Southeast Asian J Trop Med Public Health 1999;30:507-10.
• 14 Gupta E, Dar L, Narang P, Srivastava VK, Broor S. Serodiagnosis of dengue during an outbreak at a tertiary care hospital in Delhi. Indian J Med Res 2005;121:36-8.
• 15 Dar L, Gupta E, Narang P, Broor S. Co-circulation of dengue serotypes 1,2,3 and 4 during the 2003 outbreak in Delhi, India. Emerg Infect Dis 2006;12:352-3.
• 16 Dash PK, Saxena P, Abhyankar A, Bhargava R, Jana AM. Emergence of dengue virus type-3 in northern India. Southeast Asian J Trop Med Public Health 2005;36:370-7.
• 17 Rao CV. Dengue fever in India. Indian J Pediatr 1987;54:11-4.
• 18 Lall R, Dhanda V. Dengue haemorrhagic fever and the dengue shock syndrome in India. Natl Med J India 1996;9:20-3.
• 19 WHO: Dengue and Severe Dengue. Fact sheet No 117, Available from: http://www.who.int/mediacentre/factsheets/fs117/en/. [Last accessed on 2017 Apr 20].
• 20 Philip Samuel P, Tyagi BK. Diagnostic methods for detection & isolation of dengue viruses from vector mosquitoes. Indian J Med Res 2006;123:615-28.
• 21 Cecilia D, Kakade MB, Bhagat AB, Vallentyne J, Singh A, Patil JA, et al. Detection of dengue-4 virus in Pune, Western India after an absence of 30 years – Its association with two severe cases. Virol J 2011;8:46.
• 22 Kumar RR, Kamal S, Patnaik SK, Sharma RC. Breeding habitats and larval indices of Aedes aegypti in residential areas of Rajahmundry town, Andhra Pradesh. Indian J Med Res 2002;115:31-6.
• 23 Bessoff K, Delorey M, Sun W, Hunsperger E. Comparison of two commercially available dengue virus (DENV) NS1 capture enzyme-linked immunosorbent assays using a single clinical sample for diagnosis of acute DENV infection. Clin Vaccine Immunol 2008;15:1513-8.
• 24 Hang VT, Nguyet NM, Trung DT, Tricou V, Yoksan S, Dung NM, et al. Diagnostic accuracy of NS1 ELISA and lateral flow rapid tests for dengue sensitivity, specificity and relationship to viraemia and antibody responses. PLoS Negl Trop Dis 2009;3:e360.
• 25 Narayanan M, Aravind MA, Thilothammal N, Prema R, Sargunam CS, Ramamurty N. Dengue fever epidemic in Chennai – A study of clinical profile and outcome. Indian Pediatr 2002;39:1027-33.
• 26 Gomber S, Ramachandran VG, Kumar S, Agarwal KN, Gupta P, Gupta P, et al. Hematological observations as diagnostic markers in dengue hemorrhagic fever – A reappraisal. Indian Pediatr 2001;38:477-81.
• 27 Bethell DB, Gamble J, Pham PL, Nguyen MD, Tran TH, Ha TH, et al. Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. Clin Infect Dis 2001;32:243-53.
• 28 Halstead SB. Pathogenesis of dengue: Challenges to molecular biology. Science 1988;239:476-81.
• 29 Halstead SB. Dengue and Dengue Hemorrhagic Fever. New York: CAB International; 1997. p. 23-44.
• 30 World Health Organization. Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention, and Control. 2^nd ed. Geneva: World Health Organization; 1997.
• 31 Chakravarti A, Kumaria R, Sharma VK, Berry N. Serodiagnosis of dengue infection by rapid immuno chromatography test in a hospital setting in Delhi, India, 1999-2001. Dengue Bull 2002;23:109-12.
• 32 Sharma RS, Panigrahi N, Kaul SM, Shivlal, Barua K, Bhardwaj M. Status report of DF/DHF during 1998 in the National Capital Territory of Delhi, India. Dengue Bull 1999;23:109-12.